Core Scientific, Inc. CORZ Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $354.74M+11.2% | $319.02M-4.5% | $334.18M-4.1% | $348.43M-15.2% | $410.91M-19.5% | ||
| $294.95M+4.9% | $281.12M-10.0% | $312.28M-5.5% | $330.59M-8.0% | $359.27M-7.8% | ||
| $59.79M+57.8% | $37.9M+73.0% | $21.91M+22.8% | $17.85M-65.4% | $51.64M-57.3% | ||
| 16.9%+5.0pp | 11.9%+5.3pp | 6.6%+1.4pp | 5.1%-7.4pp | 12.6%-11.1pp | ||
| $171.78M+7.9% | $159.22M-13.3% | $183.62M+18.8% | $154.61M+19.8% | $129.05M+13.5% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | $3.06M+163% | -$4.84M+76.7% | -$20.8M+43.9% | ||
| —— | —— | -$601.36M+35.1% | -$926.15M-12.0% | -$827.13M+36.1% | ||
| -$23.31M-141% | -$9.68M-33.4% | -$7.25M-50.2% | -$4.83M-1,120% | -$396K+90.6% | ||
| $978K+67.8% | $583K-32.4% | $863K-1.0% | $872K+1.6% | $858K-0.1% | ||
| —— | —— | -$798.36M+27.9% | -$1.11B-3.2% | -$1.07B+25.4% | ||
| -$3.36-282% | -$0.88-483% | $0.23+148% | -$0.48+91.3% | -$5.49+8.5% | ||
| 1.3B-3.1% | 1.3B+5.0% | 1.3B+2.1% | 1.2B+12.8% | 1.1B+8.0% | ||
| 1.3B+0.6% | 1.3B+5.2% | 1.2B+2.2% | 1.2B+13.4% | 1B+8.8% | ||
| -$27.47M+13.1% | -$31.6M-208% | $29.26M+61.7% | $18.1M+247% | -$12.28M-670% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | $588.07M-36.2% | $921.73M+14.1% | $807.81M-41.0% | ||
| —— | —— | $3.06M+163% | -$4.84M+76.7% | -$20.8M+43.9% | ||
| —— | —— | —— | —— | $4.22M-12.5% | ||
| —— | —— | —— | —— | $21.97M+59.9% | ||
| -$23.31M-141% | -$9.68M-33.4% | -$7.25M-50.2% | -$4.83M-1,120% | -$396K+90.6% | ||
| $30.95M+187% | $10.78M+159% | -$18.25M-6.3% | -$17.17M-2.0% | -$16.83M-37.2% | ||
| -$36.47M-110% | -$17.4M-124% | $71.69M+87.0% | $38.35M+157% | $14.94M+695% | ||
| $912.48M+1,546% | -$63.1M-111% | $556.88M-25.2% | $744.43M-4.1% | $776.2M-7.0% | ||
| -$1.04B-40.2% | -$740.75M-49.3% | -$496.22M-81.7% | -$273.1M-79.4% | -$152.24M-59.9% | ||
| $573.17M+106% | $278.25M+100% | $138.99M+976% | $12.92M+153% | -$24.32M-157% | ||
| -$321K+31.4% | -$468K-514% | $113K-95.4% | $2.46M+8.5% | $2.27M+233% | ||
| —— | —— | —— | —— | $153.59M-16.7% | ||
| -$447.59M-147% | -$181.12M-57.1% | -$115.28M-32.9% | -$86.71M+38.2% | -$140.39M-386% | ||
| -126.2%-69.4pp | -56.8%-22.3pp | -34.5%-9.6pp | -24.9%+9.3pp | -34.2%-28.5pp | ||
| -$513.42M-105% | -$250.03M-27.5% | -$196.14M-9.0% | -$179.93M+26.4% | -$244.33M-72.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Core Scientific, Inc.'s revenue?
- Core Scientific, Inc. (CORZ) generated $354.7M in revenue over the trailing twelve months, down 13.7% year over year.
- Is Core Scientific, Inc. profitable?
- Core Scientific, Inc. is not currently profitable: it reported a net loss of $854.4M over the trailing twelve months, a -238.9% net margin.
- What are Core Scientific, Inc.'s profit margins?
- Gross margin is 16.9% and operating margin is -144.7%, with a -238.9% net margin.
- What is Core Scientific, Inc.'s earnings per share?
- Core Scientific, Inc.'s diluted EPS over the trailing twelve months is $-3.18.
- Where does Core Scientific, Inc.'s income statement data come from?
- Every line is extracted from Core Scientific, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
